Is Strata Critical Medical, Inc. (NASDAQ:SRTA) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Strata Critical Medical, Inc. at current levels.
The old Blade helicopter business is dead. What's left is a focused organ logistics monopoly hiding inside a forgotten ticker.
Where SRTA is headed
Most investors still see SRTA as Blade Air Mobility, the SPAC-era urban air taxi story that never delivered. That company is gone. What remains, after the August 2025 rebrand and the divestiture of the passenger helicopter business, is a pure-play time-critical medical logistics operator with roughly $250M in projected 2026 revenue, growing close to 40%, and the dominant private operator in organ transportation in the United States.
Read the full Compass Direction on SRTA
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $6.13).
See the full SRTA analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Strata Critical Medical, Inc. (NASDAQ:SRTA) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Strata Critical Medical, Inc. at current levels. The old Blade helicopter business is dead. What's left is a focused organ logistics monopoly hiding inside a forgotten ticker.
What is SRTA's Compass Score?
Strata Critical Medical, Inc. scores 82/100 on Alexandria's Compass, placing it in the "True North" tier. Scores blend eight factors and update weekly.
What is the price target for SRTA?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the SRTA page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.